Health
Sacubitril/valsartan drug did not significantly reduce cardiovascular death after heart attack – News-Medical.Net
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to…
The heart failure drug sacubitril/valsartan did not significantly reduce the rate of heart failure or cardiovascular death following a heart attack compared to ramipril, an angiotensin-converting enzyme(ACE)inhibitor proven effective in improving survival following heart attacks. Findings from the PARADISE-MI trial were presented at the American College of Cardiologys 70thAnnual Scientific Session.
The study is the first large trial to examine whether sacubitril/valsartan can reduce heart failure…
-
Noosa News17 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News18 hours agoA secret scheme and plans to expel former leaders — here’s what we’ve heard from Queensland’s inquiry into the CFMEU
-
Noosa News17 hours agoFatal traffic crash, Noosa – Sunshine Coast
-
Business17 hours agoTop brokers name 3 ASX shares to buy next week 23 November 2025